• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧条件下BODIPY衍生的I型光敏剂在光动力治疗后的自动失活

Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.

作者信息

Wang Xia, Wang Zhaobin, Hang He, Feng Fude

机构信息

MOE Key Laboratory of High Performance Polymer Material and Technology of Ministry of Education, Department of Polymer Science & Engineering, School of Chemistry & Chemical Engineering, Nanjing University, Jiangsu, Nanjing, 210023, P. R. China.

出版信息

Chembiochem. 2025 Feb 1;26(3):e202400767. doi: 10.1002/cbic.202400767. Epub 2024 Nov 28.

DOI:10.1002/cbic.202400767
PMID:39562291
Abstract

The long-lasting activity of photosensitizers during photodynamic therapy (PDT) causes excessive damage and arouses great concerns about biosafety. Herein, we synthesized a pyridinium-decorated diiodo-BODIPY compound (PyBDP) and investigated its photosensitizing activity under hypoxic condition in the presence of NADH that is abundant in the mitochondria of hypoxic tumors. The unique property of PyBDP lies in the redox environment-dependent photo-response. At green light exposure, PyBDP is converted into a colorless inactive form by interacting with NADH in a two-step one-electron transfer process. Interestingly, the NADH-dependent hydrogenation of PyBDP is affected by the presence of cytochrome c (Cyt c) that is an important component of mitochondrial electron transport chain (Mito-ETC), unless Cyt c is exhausted. Active radical species is produced during the photocatalytic reaction, which adds the understanding of PyBDP-induced photodamage. Therefore, we applied the strategy of auto-deactivation PDT using a BODIPY photosensitizer by tethering triphenylphosphonium to PyBDP. After PDT effect in a type I pathway, the photosensitizer underwent almost entire auto-deactivation in hypoxic HeLa cells. This work paves a way for the development of reductive PDT with enhanced safety and efficacy in fighting hypoxic tumors independent on reactive oxygen species (ROS).

摘要

光动力疗法(PDT)过程中光敏剂的持久活性会造成过度损伤,并引发对生物安全性的高度关注。在此,我们合成了一种吡啶修饰的二碘硼二吡咯化合物(PyBDP),并研究了其在缺氧条件下,在缺氧肿瘤线粒体中大量存在的烟酰胺腺嘌呤二核苷酸(NADH)存在时的光敏活性。PyBDP的独特性质在于其依赖氧化还原环境的光响应。在绿光照射下,PyBDP通过在两步单电子转移过程中与NADH相互作用,转化为无色的非活性形式。有趣的是,除非细胞色素c(Cyt c)耗尽,PyBDP的NADH依赖性氢化反应会受到线粒体电子传递链(Mito-ETC)的重要组成部分细胞色素c的影响。光催化反应过程中会产生活性自由基,这加深了对PyBDP诱导光损伤的理解。因此,我们通过将三苯基膦连接到PyBDP上,应用了一种使用硼二吡咯光敏剂的自动失活PDT策略。在I型途径的PDT效应后,光敏剂在缺氧的HeLa细胞中几乎完全自动失活。这项工作为开发在对抗缺氧肿瘤时具有更高安全性和疗效且不依赖活性氧(ROS)的还原型PDT铺平了道路。

相似文献

1
Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.缺氧条件下BODIPY衍生的I型光敏剂在光动力治疗后的自动失活
Chembiochem. 2025 Feb 1;26(3):e202400767. doi: 10.1002/cbic.202400767. Epub 2024 Nov 28.
2
Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.线粒体靶向硒吩修饰基于 BODIPY 的光敏剂用于治疗缺氧癌细胞。
ChemMedChem. 2019 Nov 20;14(22):1879-1886. doi: 10.1002/cmdc.201900380. Epub 2019 Nov 5.
3
A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy.一种简单的过氧化氢激活型 Bodipy,用于肿瘤成像和 I/II 型光动力治疗。
J Mater Chem B. 2024 Nov 6;12(43):11165-11171. doi: 10.1039/d4tb01650e.
4
Potent BODIPY-based photosensitisers for selective mitochondrial dysfunction and effective photodynamic therapy.基于强效 BODIPY 的光敏剂,用于选择性线粒体功能障碍和有效的光动力疗法。
J Mater Chem B. 2024 Oct 17;12(40):10409-10415. doi: 10.1039/d4tb01609b.
5
The Photodynamic Agent Designed by Involvement of Hydrogen Atom Transfer for Enhancing Photodynamic Therapy.通过氢原子转移参与设计的用于增强光动力疗法的光动力剂。
Angew Chem Int Ed Engl. 2025 Jan 2;64(1):e202413595. doi: 10.1002/anie.202413595. Epub 2024 Nov 14.
6
Moderately Heavy Atom-Substituted BODIPY Photosensitizer with Mitochondrial Targeting Ability for Imaging-Guided Photodynamic Therapy.具有线粒体靶向能力的中等重原子取代的BODIPY光敏剂用于成像引导的光动力治疗
ACS Appl Bio Mater. 2024 Dec 16;7(12):8294-8304. doi: 10.1021/acsabm.4c01108. Epub 2024 Nov 27.
7
Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic Therapy.苯硫脲偶联的 BODIPY 作为一种有效的用于酪氨酸酶阳性黑色素瘤靶向光动力治疗的光敏剂。
ACS Appl Bio Mater. 2021 Mar 15;4(3):2120-2127. doi: 10.1021/acsabm.0c01322. Epub 2020 Nov 24.
8
BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.载有二吡咯亚甲基(BODIPY)的姜黄素药物锌(II)配合物,用于可见光辅助光动力疗法、细胞成像和靶向 PDT。
Eur J Med Chem. 2021 Aug 5;220:113438. doi: 10.1016/j.ejmech.2021.113438. Epub 2021 Apr 20.
9
A photo-degradable BODIPY-modified Ru(II) photosensitizer for safe and efficient PDT under both normoxic and hypoxic conditions.一种光降解的 BODIPY 修饰的 Ru(II)光敏剂,可在常氧和缺氧条件下实现安全高效的 PDT。
Dalton Trans. 2024 Feb 20;53(8):3579-3588. doi: 10.1039/d3dt04063a.
10
An Ethacrynic Acid-Brominated BODIPY Photosensitizer (EA-BPS) Construct Enhances the Lethality of Reactive Oxygen Species in Hypoxic Tumor-Targeted Photodynamic Therapy.一种依可酸-溴代 BODIPY 光敏剂(EA-BPS)构建体增强了乏氧肿瘤靶向光动力治疗中活性氧的致死性。
Angew Chem Int Ed Engl. 2021 Feb 8;60(6):3196-3204. doi: 10.1002/anie.202012687. Epub 2020 Dec 16.